Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

NCT02807987 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension With Moderate Renal Impairment

Interventions

DRUG: CS-3150

Sponsor

Daiichi Sankyo Co., Ltd.